The stronger impact on cancer cells may be attributed to the deficiency of 5-methylthioadenosine phosphorylase (MTAP), a key enzyme in the methionine salvage pathway (Fig 1B), which is also notably absent in most cancers [10,12–14,32]. Here, MTAP is linked to cancer.